Biotechnology

B&K CORP-B

B&K CORP-B released FY2025 Q4 earnings on March 30, 2026 (BJT), with actual revenue of HKD 580.48 K and EPS of HKD -0.8142

B&K CORP-B released FY2025 earnings on March 30, 2026 (BJT) with actual revenue of HKD 570.53K and EPS of HKD -2.2738

B&K CORP-B FY2025 Annual Earnings Release on March 30, 2026 (BJT)

B&K CORP-B released FY2024 annual earnings on December 12, 2025 (BJT), actual revenue HKD 282.53 K, actual EPS HKD -2.3291

B&K CORP-B released FY2023 Annual Earnings on December 12, 2025 (BJT), with actual revenue of HKD 518.33K and EPS of HKD -1.3237

2396.HK released FY2024 Q4 earnings on December 12 (BJT), actual revenue HKD 277.67 K, actual EPS HKD -0.5122

QINGDAO HLDGS

QIANHAI HEALTH

GUOXIA TECH

BITSTRAT HLDGS

KIN SHING HLDGS

AV CONCEPT HOLD

DATRONIX HOLD

HAITIAN ANTENNA

PRODUCTIVE TECH

INVESTECH HLDGS

3SBIO

BEONE MEDICINES

INNOVENT BIO

REMEGEN

HENLIUS

BIOCYTOGEN-B

INNOCARE

GENFLEET-B

EVEREST MED

HBM HOLDINGS-B

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

B&K CORP-B(02396.HK)

B&K CORP-B Stock Performance Chart